# OnKure Therapeutics

**Canonical:** https://apis.io/providers/onkure-therapeutics/  
**Website:** https://onkuretherapeutics.com/  
**APIs profiled:** 0

OnKure Therapeutics (Nasdaq: OKUR) is a publicly traded, clinical-stage biopharmaceutical company headquartered in Boulder, Colorado, developing precision medicines for people with cancer. The company designs mutant-selective small-molecule inhibitors against oncogenic drivers in the PI3K pathway; its lead program OKI-219 is a selective PI3K-alpha H1047R inhibitor in clinical development, with additional discovery programs targeting further PI3K-alpha mutations. OnKure became publicly listed through its 2024 combination with Reneo Pharmaceuticals. It is a therapeutics developer rather than a software vendor: it operates a corporate and investor relations web presence and publishes no developer program, public API, SDK, or machine-readable API contract.

## Kin Score — 10.0 / 100 (minimal)

Scored 2026-09-02 under rubric 0.18.0. Trend: flat (+0.0 from 10.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Onkure Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Oncology, Precision Medicine, Clinical Trials, Life Sciences, Drug Discovery, Publicly Traded

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/onkure-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.